Camptosar (irinotecan), the first new drug for colorectal cancer in 40 years
July 1996
You'll also see Camptosar (irinotecan), the first new drug for colorectal cancer in 40 years. From Pharmacia & Upjohn.
It's in the same new class as Hycamtin.
Camptosar will be used as second-line therapy...for cancer that progresses after standard therapy with 5-fluorouracil.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote